INNATE PHARMA SA (IPH.PA)
FR0010331421 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -7.57M | -58.10M | -52.81M | -63.98M | -20.76M | |||
| Depreciation Amortization | 5.09M | 45.41M | 4.60M | 56.80M | 16.53M | |||
| Change In Working Capital | -32.09M | -12.50M | -9.57M | -48.87M | 40.45M | |||
| Interest Paid | 0.00 | 0.00 | 312.00K | 341.00K | 204.00K | |||
| Other non cash items | 2.01M | 6.05M | -672.00K | 4.28M | -1.29M | |||
| OPERATING CASH FLOW | -32.56M | -19.15M | -58.45M | -51.77M | 34.92M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.35M | -1.12M | -1.33M | -11.34M | -65.41M | |||
| Other Investing Activity | 22.98M | 3.00M | 414.00K | -2.03M | 3.29M | |||
| INVESTING CASH FLOW | 20.63M | 1.88M | -917.00K | -13.37M | -62.12M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -2.36M | -2.03M | 26.63M | -885.00K | 11.92M | |||
| Stock Issued/Repurchased | 395.00K | 198.00K | 499.00K | 48.00K | 66.05M | |||
| Other Financing Activity | 0.00 | 0.00 | -312.00K | -340.00K | -203.00K | |||
| FINANCING CASH FLOW | -1.97M | -1.83M | 26.82M | -1.18M | 77.77M | |||
| Exchange Rate Effect | 274.00K | -428.00K | -483.00K | 219.00K | 5.00K | |||
| CHANGE IN CASH | -13.62M | -19.53M | -33.04M | -66.10M | 50.57M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -32.56M | -19.15M | -58.45M | -51.77M | 34.92M | |||
| Capital Expenditure | -2.35M | -1.12M | -1.33M | -11.34M | -65.41M | |||
| FREE CASH FLOW | -34.91M | -20.28M | -59.79M | -63.11M | -30.49M | |||
All data in EUR